Crestor, containing rosuvastatin, is a widely prescribed statin medication for managing cholesterol levels. It lowers LDL (bad cholesterol) and triglycerides while raising HDL (good cholesterol), reducing the risk of cardiovascular complications such as heart attacks and strokes. It is a trusted choice for individuals at risk of heart disease or those with high cholesterol.
Benefits of Crestor:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
More information about Crestor:
References -- Astec v4 (2002) 73:12 -- Stat mot mot Stat -- AstraZeneca v3 (2010) 39:9 -- AstraZeneca v2 (2011) 42:49 -- AstraZeneca v1 (2018) 204:11 -- AstraZeneca v1 (2021) 222:25 -- AstraZeneca v2 (2022) 205:25 -- AstraZeneca v3 (2023) 227:67 -- AstraZeneca v1 (2024) 225:43 -- AstraZeneca v2 (2025) 227:59 -- AstraZeneca v1 (2026) 225:73 -- AstraZeneca v1 (2027) 225:81 -- AstraZeneca v1 (2028) 227:59 -- Rosuvastatin calcium 20 mg capsules Tablet -- AstraZeneca v3 (2022) 227:67 -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Astro-Zeneca v3 (2023) 227:59 -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsules Tablet -- Rosuvastatin calcium 20 mg capsulesLast updated: 2024-12-30
Inmoreuton crestor was the original statin. It was also the brand name for rosuvastatin, a statin commonly used to lower cholesterol levels.
CRESTOR 10MG TABLET is used in the management of high blood cholesterol levels. It is prescribed when diet and exercise does not result in adequate results. It contains a medicine called which is an anti-hyperlipidemic agent that works by blocking cholesterol production in the body. It also makes your body eliminate lipids particles from the blood.
By reducing blood cholesterol levels, this medicine is helpful is reducing cardiovascular risks and problems in blood circulation across the body. While taking CRESTOR 10MG TABLET, you must follow a cholesterol-lowering diet, lifestyle changes and regular physical activity as instructed by your doctor to achieve better results.
Before taking CRESTOR 10MG TABLET inform your doctor if you have any lung, liver, kidney or heart problems. You must also inform your doctor if you have diabetes, thyroid problems, or a family history of muscle disorders. Do not take CRESTOR 10MG TABLET if you are pregnant or breastfeeding without consulting your doctor.
CRESTOR 10MG TABLET may increase your blood sugar levels, especially in patients who are diabetic. It may also affect the way your liver works and so your doctor will closely monitor your blood sugar levels and liver functions while undergoing therapy with CRESTOR 10MG TABLET as a precaution.
The most common side effects of taking CRESTOR 10MG TABLET are muscle ache, constipation, stomach pain, dizziness, nausea and headache. Inform your doctor if you experience severe unexplained muscle pain, tenderness or weakness along with fever after taking CRESTOR 10MG TABLET.
How should I take CRESTOR 10MG TABLET?ry must take regular check-ups before taking CRESTOR 10MG TABLET as instructed by your doctor. A cholesterol-lowering diet, lifestyle changes and regular follow-up doctor’s consultation is recommended to know if taking CRESTOR 10MG TABLET is helping your health. Before you take CRESTOR 10MG TABLET, inform your doctor if you are pregnant or breastfeeding.Inform your doctor if you experience severe side effects including black hairy tongue, difficulty breathing, nausea and vomiting. They may be able to prescribe you you under medical supervision or you may need to contact your doctor for medical advice about not taking CRESTOR 10MG TABLET.
How should I keep CRESTOR 10MG TABLET?They also may interact with other drugs and conditions beyond blood cholesterol levels such as hypertension, cholesterol-related conditions such as high blood pressure,olesteroleabo, bleeding problems, unexplained fever, or unusual vaginal bleeding.
Taking CRESTOR 10MG TABLET may cause dizziness, lightheadedness, fainting, fainting-like symptoms, prolonged headache, nervousness, sleep problems, changes in mood, suicidal ideation, fits or fits, or priapism (prolonged erection of the penis) can occur. To avoid these symptoms and other side effects, limit your intake of caffeine, alcohol, cholesterol-related medication and antipathy medication as well. Consult your doctor if you are pregnant or breastfeeding.
Before taking CRESTOR 10MG TABLET, inform your doctor if you are pregnant or breastfeeding. It is not recommended for use in children (aged below 18 years) as it is potentially harm to the baby. It is not normal for taking CRESTOR 10MG TABLET during pregnancy and breastfeeding.
To reduce the risk of side effects from taking CRESTOR 10MG TABLET, coxia spp., advises doctors of diet and exercise. Avoid consuming high cholesterol foods, drinks, nuts, seeds and complex carbohydrates during treatment with CRESTOR 10MG TABLET.
Avoid excessive stops or stretches for at least 4 hours before and during therapy with CRESTOR 10MG TABLET to avoid muscle pain, tenderness and/or weakness. Avoid unnecessary stops and stretches to a maximum of 4 hours.
ConstipationBe sure to inform your doctor if you have any lung, liver or kidney problems. You must also inform your doctor if you have diabetes, thyroid problems, diabetes T or D or diabetes C or heart disease. If you are experiencing significant constipation, consult your doctor about how you should avoid having alcohol while taking CRESTOR 10MG TABLET.
Constipation is a loose and crumbly feeling in the stomach. It is usually mild to lightheaded, uncomfortable and often lasts a few minutes.
Rationale for the treatment of heart failure in patients with advanced heart failure: a review of pharmacokinetic, pharmacodynamics, and clinical data.
The pharmacokinetic parameters were evaluated in 3 separate trials, a total of 6 to 10 subjects in each trial, and the results showed that the mean AUC values were approximately equivalent within the range of 2–6%, and that the AUC values increased with dose (see Table ).
AUCs in the blood were approximately 3–5% higher after once-daily dosing compared with once-daily administration (see Table ).
In contrast, the AUCs in the liver were about 3% lower after once-daily dosing compared with once-daily administration (see Table ).
There were no statistically significant differences between the mean AUC values in the liver or blood in patients receiving Crestor and the placebo groups. AUC values were similar between Crestor and the placebo group, but in the liver, the mean AUC in the Crestor group was approximately 1.2% higher compared with the placebo group. There was no statistical significance with respect to the AUC values in the blood, AUC, or liver.
The AUC values in the blood were approximately 1.5% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In the plasma, the mean AUC values in the Crestor group were approximately 1.3% higher compared with the placebo group, but the difference did not reach statistical significance (see Table ).
AUCs in the plasma were approximately 3.1% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In the blood, the AUCs in the Crestor group were approximately 1.5% higher compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In patients with mild to moderate (Child-Pugh class A or B), AUCs were approximately 2% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
AUCs were similar between the Crestor and placebo groups, but the difference did not reach statistical significance (see Table ).
The AUCs in the plasma in the Crestor group were approximately 2.1% higher compared with the placebo group, and the difference did not reach statistical significance (see Table ).
In the blood, AUCs in the Crestor group were approximately 1.3% higher compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In patients with moderate to severe (Child-Pugh class B or C), AUCs were approximately 1.2% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
There were no statistically significant differences between the mean AUC values in the Crestor and placebo groups. AUCs in the liver were about 3.6% lower in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
AUCs in the blood were approximately 3.1% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In the plasma, the AUCs in the Crestor group were approximately 1.6% lower compared with the placebo group, but the difference did not reach statistical significance (see Table ).
The mean AUCs in the Crestor and placebo groups were approximately 1.4% higher in the Crestor group compared with the placebo group, but the difference did not reach statistical significance (see Table ).
In patients with moderate to severe (Child-Pugh class B or C), AUCs were approximately 1.
AstraZeneca is to cut the cholesterol-lowering drug Crestor by 40 per cent on Tuesday, Health Canada said on Thursday.
The Canadian Health Products Regulatory Agency said the drug, which blocks the cholesterol-lowering drug, Crestor, will be removed from sale in the United States on Wednesday and other countries, including Australia and Canada, will also continue to sell it.
The drug's patent for the statin Merit Rx has expired in the United States, the FDA said in its notice of intent to halt distribution of the drug. The agency has also not yet decided whether to sell the drug in other countries.
The agency's notice of intent said the drug has been "discontinued" in the U. S. and Canada. It was not authorized for sale in Australia and Canada, it said.
It was "notifying the Canadian Food and Drug Administration (CFCA) and the Australian and New Zealand Medicines and Healthcare Products Regulatory Agency (ANPR), that Crestor was not being distributed in the U. S.," the notice said. It added that the drug's U. distributor has also not stopped making claims against the agency for the drug.
The agency said the drug had been under development since 2009.
The Canadian Health Products Regulatory Agency said it will begin finalizing the drug's approval in October.
Crestor, which is sold under the name Crestor, had been on the market since 2006. The drug has been under investigation by the FDA since the year 2009.
Crestor is one of several cholesterol-lowering drugs that are also used to treat high cholesterol and prevent heart disease.
Copyright 2017 Health Canada LtdCiprioniProduct variantsThe company is listed in the Canadian securities exchange market as a trading name of its trading platform.
Shares of AstraZeneca fell 1.5 per cent to $32.56 in afternoon trading, closing at $38.55.
Post navigationThe company is listed in the Canadian securities market as a trading name of its trading platform.
In order to be eligible for the stock, patients must have met the criteria listed in the "Buy and Sell" section of the company's "Sale" form, as well as be at least one year post-approval.
Stade de France Pharmacy